Comparative Study of Three NNRTI-Sparing HAART Regimens

Condition:   HIV InfectionInterventions:   Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: AtazanavirSponsors:   AIDS Clinical Trials Group;   National Institute of Allergy and Infectious Diseases (NIAID);   Bristol-Myers Squibb;   Gilead Sciences;   Merck Sharp & Dohme Corp.;   Tibotec Therapeutics, a Division of Ortho Biotech Products, L.P., USACompleted - verified September 2014
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials